Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly pathogenic
novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID …

Objectives To clarify the work done by using AI for identifying the genomic sequences,
development of drugs and vaccines for COVID-19 and to recognize the advantages and …

Motivation Drug combination therapy has become an increasingly promising method in the
treatment of cancer. However, the number of possible drug combinations is so huge that it is …

The severe acute respiratory syndrome–coronavirus 2 (SARS‐CoV‐2), the infectious agent
responsible for COVID‐19–has caused more than 2.5 million deaths worldwide and …

The unforeseen emergence of coronavirus disease 2019 (COVID-19), a severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) at the Wuhan province of China in …

The recent outbreak of coronavirus disease (COVID‐19) in China caused by the severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to worldwide human …

Since the outbreak emerged in November 2019, no effective drug has yet been found
against SARS-CoV-2. Repositioning studies of existing drug molecules or candidates are …

Coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, has become a
worldwide pandemic. Symptoms range from mild fever to cough, fatigue, severe pneumonia …

Structurally diverse piperazine-based compounds hybrid with thiadiazole, isatin or with
sulfur/nitrogen, functionalities were synthesized. The structures of the new compounds were …

At the end of 2019, a novel virus causing severe acute respiratory syndrome to spread
globally. There are currently no effective drugs targeting SARS-CoV-2. In this study, based …